Franklin Biotechnology Discv Z(acc)GBP
Pricing frequency
Daily
Dealing cut off time
15:00
Type
SICAV
Yield
-
NAV
£45.79
Ongoing charge
1.31%
Latest actual NAV date
28-03-2024
ISIN
LU0774687577
UCITS
Yes
This fund can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Regular investment
Before investing please read:
Growth of 10k
Asset allocation
Top 10 holdings
Holdings 29/02/2024 | % of assets |
---|---|
Amgen Inc | 6.58 |
Regeneron Pharmaceuticals Inc | 6.24 |
Vertex Pharmaceuticals Inc | 5.20 |
Ascendis Pharma A/S ADR | 3.99 |
Gilead Sciences Inc | 2.92 |
Intra-Cellular Therapies Inc | 2.81 |
Biogen Inc | 2.80 |
AstraZeneca PLC ADR | 2.75 |
Jazz Pharmaceuticals PLC | 2.55 |
Merus NV | 2.35 |
Investment objective
The Fund’s investment objective is capital appreciation.
Morningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.